Savara, Inc. (SVRA)
4.96
-0.20
(-3.88%)
USD |
NASDAQ |
Mar 20, 16:00
4.98
+0.02
(+0.40%)
After-Hours: 20:00
Savara Total Liabilities (Quarterly) : 50.30M for Dec. 31, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Spyre Therapeutics, Inc. | 62.54M |
| ACADIA Pharmaceuticals, Inc. | 336.80M |
| Alnylam Pharmaceuticals, Inc. | 4.236B |
| BioMarin Pharmaceutical, Inc. | 1.507B |
| Imunon, Inc. | 4.906M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 253.44M |
| Shareholders Equity (Quarterly) | 203.13M |
| Debt to Equity Ratio | 0.1473 |
| Current Ratio | 11.85 |
| Net Debt Paydown Yield | -0.05% |